SCHEMBL486027

SCHEMBL486027

O=C(NC1CCC1)c1ccc2ccccc2c1OCc1nc2ccccc2s1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 1/20 0.50
NPC1 O15118 6/20 0.47
CXCR6 O00574 1/20 0.47
SMN1; SMN2 Q16637 5/20 0.46
ALDH1A1 P00352 3/20 0.46
KDM4E B2RXH2 2/20 0.46
LMNA P02545 1/20 0.46
RAB9A P51151 6/20 0.46
ALOX5 P09917 2/20 0.44
ALOX5AP P20292 1/20 0.44
FEN1 P39748 1/20 0.44
EPHX2 P34913 1/20 0.44
KMT2A Q03164 4/20 0.43
MEN1 O00255 2/20 0.43
NFKB1 P19838 1/20 0.43
NFKB2 Q00653 1/20 0.43
RELA Q04206 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2C19 P33261 1/20 0.43
GAA P10253 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL485598 0.98 MAOB (0.53) MAOBNPC1CXCR6SMN1; SMN2ALDH1A1
Formic Acid SCHEMBL27693206 0.96 MAOB (0.47) MAOBNPC1CXCR6SMN1; SMN2ALDH1A1
SCHEMBL486121 0.87 MAOB (0.47) MAOBNPC1CXCR6SMN1; SMN2ALDH1A1
SCHEMBL486258 0.86 MAOB (0.52) MAOBNPC1CXCR6SMN1; SMN2ALDH1A1
SCHEMBL485800 0.85 KMT2A (0.49) MAOBNPC1CXCR6SMN1; SMN2ALDH1A1
Formic Acid SCHEMBL28768792 0.85 MAOB (0.45) MAOBNPC1CXCR6SMN1; SMN2ALDH1A1
Bicarbonate SCHEMBL485447 0.84 MAOB (0.50) MAOBNPC1CXCR6SMN1; SMN2ALDH1A1
Formic Acid SCHEMBL27693254 0.83 MAOB (0.48) MAOBNPC1CXCR6SMN1; SMN2ALDH1A1
SCHEMBL485628 0.81 CXCR2 (0.58) NPC1SMN1; SMN2ALDH1A1KDM4ERAB9A
SCHEMBL484358 0.81 CXCR2 (0.56) NPC1SMN1; SMN2ALDH1A1KDM4ERAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1836158-B1 FUSED BICYCLIC CARBOXAMIDE DERIVATIVES FOR USE AS CXCR2 INHIBITORS IN THE TREATMENT OF INFLAMMATION SANOFI AVENTIS DEUTSCHLAND (DE) 2012-02-01 EP claimed